NCT04314375: Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis |
|
|
| Recruiting | 4 | 70 | US | Low Dose Budesonide, High Dose Budesonide, Placebo | Bausch Health Americas, Inc. | Ulcerative Colitis | 12/24 | 12/24 | | |
